SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO.,LTD
About SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO.,LTD
Sichuan Yuanda Shuyang Pharmaceutical Co Ltd (Shuyang) was founded in 1985 and now is a subsidiary of China Grand Enterprises, Inc. The total asset of Shuyang is more than 1.5 billion Yuan, with 1.5 billion Yuan of annual sales revenue in 2018. The company has 17 subsidiary plasmapheresis centers. The products are selling all over the country and already entering into inte...
Products from SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO.,LTD (3)
The main component of this preparation is human albumin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process of human albumin contains a step of heating the final solution at 60℃ for 10 hours to inactivate the viruses present in it. It contains...
The manufacturing process for human hepatitis B immunoglobulin contains a step of low pH incubation for viral inactivation. It contains a suitable amount of glycine as stabilizer, but does not contain any antiseptic or antibiotic.
-Post-exposure prophylaxis should be c...
Major constituent: Human hepatitis B immunoglobulin; Subsidiary material: Maltose
Indications:Use of the product in combination with lamivudine can prevent patients with HBV (hepatitis B virus)-related diseases from being re-infected with HBV after liver transplantation.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance